The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Hallervorden-Spatz Syndrome
Abstract
Two sisters with Hallervorden-Spatz syndrome (HSS) were treated with anti-Parkinson drugs. One showed the typical neuropathological lesions at death. The surviving sister has been treated with an iron-chelater without sustained effect, and with levodopa with improvement of motor abnormalities. Of 64 cases thought to represent HSS and studied post mortem, a group of 42 forms a distinct clinicopathologic entity. The remaining cases differ considerably from these, making their classification difficult at present. Hallervorden-Spatz syndrome may be the result of an inborn error of metabolism. Future studies of patients with HSS should include catecholamine analyses of cerebrospinal fluid and brain tissue and a search for viral infection, as iron studies have not been helpful.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The effect of age on the non-haemin iron in the human brain
Hallgren, B., & Sourander, P. (1958) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1958.tb12607.x · Cited by 1,427
Hallervorden, J., & Spatz, H. (1922) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02878455 · Cited by 253
Spatz, H. (1922) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02865844 · Cited by 251
Forno, L. S. (1969) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1969.tb01316.x · Cited by 215
Neuroaxonal Dystrophy in Man: Character and Natural History
Jellinger, K. A., & Jirásek, A. (1971) · Springer eBooks · doi:10.1007/978-3-642-47449-1_2 · Cited by 76
Axonal dystrophy in the gracile nucleus of man
Brannon, W., McCormick, W. F., & Lampert, P. W. (1967) · Acta Neuropathologica · doi:10.1007/bf00688153 · Cited by 57
Fujisawa, K. (1967) · Acta Neuropathologica · doi:10.1007/bf00688827 · Cited by 56
A Study of Iron Metabolism in Neuropsychiatric Patients: Hallervorden-Spatz Disease
SZANTO, J., & Gallyas, F. (1966) · Archives of Neurology · doi:10.1001/archneur.1966.00470100094012 · Cited by 47
The Management of Parkinson's Disease
England, A. C., & SCHWAB, R. S. (1959) · Archives of Internal Medicine · doi:10.1001/archinte.1959.00270090093017 · Cited by 28
Bots, G. T. A. M., & Staal, A. (1973) · Neurology · doi:10.1212/wnl.23.1.35 · Cited by 16
Cited by
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481
A permease-oxidase complex involved in high-affinity iron uptake in yeast.
Stearman, R., Yuan, D. S., Yamaguchi-Iwai, Y., Klausner, R. D., & Dancis, A. (1996) · Science · doi:10.1126/science.271.5255.1552 · Cited by 683
Clinical and genetic delineation of neurodegeneration with brain iron accumulation
Gregory, A., Polster, B. J., & Hayflick, S. J. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.061929 · Cited by 364
Giasson, B. I., Ischiropoulos, H., Lee, V. M.-Y., & Trojanowski, J. Q. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00804-3 · Cited by 279
Neuropathology of synuclein aggregates: New insights into mechanisms of neurodegenerative diseases
Duda, J. E., Lee, V. M.-Y., & Trojanowski, J. Q. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000715)61:2<121::aid-jnr1>3.0.co;2-4 · Cited by 264
Metadata
- Authors
- Dooling, E. C., Schoene, W. C., & Richardson, E. P.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 1974-01-01
- Volume
- 30
- Issue
- 1
- Pages
- 70-83
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W1974804543
- Cited by
- 269
- References
- 11
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hallervorden-Spatz Syndrome. https://app.cochat.ai/papers/10.1001/archneur.1974.00490310072012
- The paper
- Dooling, E. C., Schoene, W. C., & Richardson, E. P. (1974). Hallervorden-Spatz Syndrome. Archives of Neurology. https://doi.org/10.1001/archneur.1974.00490310072012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
